BioNxt Solutions Inc.
BNXTF
$0.46
$0.024.07%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.41M | -4.32M | -4.09M | -3.88M | -4.77M |
| Total Depreciation and Amortization | 21.10K | 34.00K | 45.80K | 67.10K | 82.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.59M | 1.65M | 1.59M | 1.02M | 1.07M |
| Change in Net Operating Assets | -918.30K | 226.50K | 55.40K | 584.60K | 1.22M |
| Cash from Operations | -3.71M | -2.41M | -2.39M | -2.21M | -2.39M |
| Capital Expenditure | -- | -- | -- | -- | -62.00K |
| Sale of Property, Plant, and Equipment | 94.60K | 59.30K | 99.10K | 41.10K | 263.30K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -36.30K | -- | -- | -- | -- |
| Cash from Investing | 58.30K | 59.30K | 99.10K | 41.10K | 201.30K |
| Total Debt Issued | 6.75M | 5.50M | 5.50M | 2.11M | -- |
| Total Debt Repaid | -2.74M | -2.74M | -1.03M | -1.03M | -9.30K |
| Issuance of Common Stock | 2.06M | 704.40K | 1.22M | 1.85M | 2.66M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -581.90K | -466.90K | -2.22M | -282.70K | -198.50K |
| Cash from Financing | 3.93M | 2.12M | 2.46M | 1.92M | 1.80M |
| Foreign Exchange rate Adjustments | 1.10K | 1.50K | 1.70K | 1.20K | 2.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 275.20K | -230.40K | 170.30K | -245.00K | -384.30K |